The process e + e − → nn has been studied at the VEPP-2000 e + e − collider with the SND detector in the energy range from threshold up to 2 GeV. As a result of the experiment, the e + e − → nn cross section and effective neutron form factor have been measured.
In the experiment with the SND detector at the VEPP-2000 e + e − collider the cross section for the process e + e − → ηπ + π − has been measured in the center-of-mass energy range from 1.22 to 2.00 GeV. Obtained results are in agreement with previous measurements and have better accuracy. The energy dependence of the e + e − → ηπ + π − cross section has been fitted with the vector-meson dominance model. From this fit the product of the branching fractions B(ρ(1450) → ηπ + π − )B(ρ(1450) → e + e − ) has been extracted and compared with the same products for ρ(1450) → ωπ 0 and ρ(1450) → π + π − decays. The obtained cross section data have been also used to test the conservation of vector current hypothesis.
The cross section of the process e+e− → π+π− has been measured in the Spherical Neutral Detector (SND) experiment at the VEPP-2000 e+e− collider VEPP-2000 in the energy region 525 <$$ \sqrt{s} $$
s
< 883 MeV. The measurement is based on data with an integrated luminosity of about 4.6 pb−1. The systematic uncertainty of the cross section determination is 0.8% at $$ \sqrt{s} $$
s
> 0.600 GeV. The ρ meson parameters are obtained as mρ = 775.3 ± 0.5 ± 0.6 MeV, Γρ = 145.6 ± 0.6 ± 0.8 MeV, Bρ→e+e− × Bρ→π+π− = (4.89 ± 0.02 ± 0.04) × 10−5, and the parameters of the e+e− → ω → π+π− process, suppressed by G-parity, as Bω→e+e− × Bω→π+π− = (1.32 ± 0.06 ± 0.02) × 10−6 and and ϕρω = 110.7 ± 1.5 ± 1.0 degrees.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.